Search results for "profiling"

showing 10 items of 881 documents

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular progn…

2014

Abstract Purpose: To optimize neuroblastoma treatment stratification, we aimed at developing a novel risk estimation system by integrating gene expression–based classification and established prognostic markers. Experimental Design: Gene expression profiles were generated from 709 neuroblastoma specimens using customized 4 × 44 K microarrays. Classification models were built using 75 tumors with contrasting courses of disease. Validation was performed in an independent test set (n = 634) by Kaplan–Meier estimates and Cox regression analyses. Results: The best-performing classifier predicted patient outcome with an accuracy of 0.95 (sensitivity, 0.93; specificity, 0.97) in the validation coh…

OncologyMaleCancer ResearchMultivariate statisticsmedicine.medical_specialtyKaplan-Meier EstimateBioinformaticsRisk AssessmentNeuroblastomaText miningRisk FactorsInternal medicineNeuroblastomamedicineBiomarkers TumorCluster AnalysisHumansbusiness.industryProportional hazards modelGene Expression ProfilingReproducibility of ResultsRegression analysismedicine.diseasePrognosisClinical trialGene expression profilingGene Expression Regulation NeoplasticOncologyRegression AnalysisFemalebusinessRisk assessmentFollow-Up StudiesClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks.

2005

Our aim was to evaluate in oral squamous cell carcinoma (OSCC) the relationship between some cell cycle markers and HPV infection, conditionally to age, gender and certain habits of patients, and to assess the ability of fuzzy neural networks (FNNs) in building up an adequate predictive model based on logic inference rules. Eighteen cases of OSCC were examined by immunohistochemistry for MIB-1, PCNA and survivin expression; presence of HPV DNA was investigated in exfoliated oral mucosa cells by nested PCR (nPCR, MY09-MY11/GP5-GP6), and HPV genotype was determined by direct DNA sequencing. Data were analyzed by traditional statistics (TS) and FNNs. HPV DNA was found in 9/18 OSCCs (50.0 %) wi…

OncologyMaleCancer ResearchSurvivinmedicine.disease_causeInhibitor of Apoptosis ProteinsRisk FactorsOral mucosaPapillomaviridaeAged 80 and overCell CycleSmokingHPV infectionAge FactorsAnatomical pathologyCell cycleMiddle AgedImmunohistochemistryNeoplasm Proteinsoral squamous cell carcinomamedicine.anatomical_structureCell Transformation NeoplasticOncologyCarcinoma Squamous CellImmunohistochemistryFemaleMouth NeoplasmscarcinogenesisMicrotubule-Associated ProteinsAdultmedicine.medical_specialtyBiologySex FactorsFuzzy LogicInternal medicineSurvivinmedicineHumanshuman papillomaviruAgedfuzzy neural networkGene Expression ProfilingPapillomavirus Infectionsmedicine.diseaseProliferating cell nuclear antigenstomatognathic diseasesImmunologyDNA Viralbiology.proteinNeural Networks ComputerCarcinogenesisInternational journal of cancer
researchProduct

Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer

2021

Abstract Purpose: The consensus molecular subtypes (CMS) represent a significant advance in the understanding of intertumor heterogeneity in colon cancer. Intratumor heterogeneity (ITH) is the new frontier for refining prognostication and understanding treatment resistance. This study aims at deciphering the transcriptomic ITH of colon cancer and understanding its potential prognostic implications. Experimental Design: We deconvoluted the transcriptomic profiles of 1,779 tumors from the PETACC8 trial and 155 colon cancer cell lines as weighted sums of the four CMSs, using the Weighted In Silico Pathology (WISP) algorithm. We assigned to each tumor and cell line a combination of up to three …

OncologyMaleCancer Researchmedicine.medical_specialtyMultivariate analysisColorectal cancer[SDV]Life Sciences [q-bio]CellContext (language use)[SDV.CAN]Life Sciences [q-bio]/CancerBiologyTranscriptome[SDV.CAN] Life Sciences [q-bio]/CancerInternal medicineCell Line TumormedicineTumor MicroenvironmentHumansTreatment resistancehealth care economics and organizationsAgedbusiness.industryGene Expression ProfilingHazard ratiomedicine.diseasePrognosisSurvival Rate[SDV] Life Sciences [q-bio]medicine.anatomical_structureOncologyColonic NeoplasmsFemalePersonalized medicinebusiness
researchProduct

The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions

2013

The validated EndoPredict assay is a novel tool to predict the risk of metastases of patients with estrogen receptor positive, HER2 negative breast cancer treated with endocrine therapy alone. It has been designed to integrate genomic and clinical information and includes clinico-pathological factors such as tumor size and nodal status. The test is feasible in a decentral setting in molecular pathology laboratories. In this project, we investigated the performance of this test in clinical practice, and performed a retrospective evaluation of its impact on treatment decisions in breast cancer. During one year, EndoPredict assays from 167 patients could be successfully performed. For retrospe…

OncologyNon-Clinical Medicinemedicine.medical_treatmentCancer Treatmentlcsh:MedicineEstrogen receptorBioinformaticsMetastasisSurveys and QuestionnairesPathologylcsh:ScienceMultidisciplinaryMolecular pathologyCancer Risk FactorsHormonal TherapyObstetrics and GynecologyEndocrine TherapyMiddle AgedOncologyReceptors EstrogenCohortMedicineFemaleRisk assessmentMolecular PathologyResearch ArticleAdultmedicine.medical_specialtyAntineoplastic Agents HormonalGenetic Causes of CancerClinical Decision-MakingBreast NeoplasmsRisk AssessmentBreast cancerDiagnostic MedicineInternal medicineBreast CancermedicineHumansAgedRetrospective StudiesChemotherapyHealth Care Policybusiness.industryGene Expression Profilinglcsh:RHealth Risk AnalysisRetrospective cohort studyChemotherapy and Drug Treatmentmedicine.diseaselcsh:QbusinessGeneral PathologyPLoS ONE
researchProduct

Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.

2019

In prostate adenocarcinoma (PCa), distinction between indolent and aggressive disease is challenging. Around 50% of PCa are characterized by TMPRSS2‐ERG (T2E)‐fusion oncoproteins defining two molecular subtypes (T2E‐positive/negative). However, current prognostic tests do not differ between both molecular subtypes, which might affect outcome prediction. To investigate gene‐signatures associated with metastasis in T2E‐positive and T2E‐negative PCa independently, we integrated tumor transcriptomes and clinicopathological data of two cohorts (total n = 783), and analyzed metastasis‐associated gene‐signatures regarding the T2E‐status. Here, we show that the prognostic value of biomarkers in PCa…

OncologyProstate adenocarcinomaMaleCancer Researchmedicine.medical_specialtyOncogene Proteins FusionKaplan-Meier EstimateAdenocarcinomaTMPRSS2MetastasisTranscriptome03 medical and health sciences0302 clinical medicineInternal medicinemedicineBiomarkers TumorHumansPrognostic biomarkerMetastasis ; Personalized Medicine ; Prognostic Biomarker ; Prostate Adenocarcinoma ; Tmprss2-ergNeoplasm MetastasisNeoplasm Stagingbusiness.industryGene Expression ProfilingComputational BiologyProstatic Neoplasmsmedicine.diseasePrognosisImmunohistochemistryGene Expression Regulation NeoplasticOncology030220 oncology & carcinogenesisImmunohistochemistryPersonalized medicineNeoplasm GradingbusinessErgInternational journal of cancerReferences
researchProduct

Genome-wide association study identifies five loci associated with lung function

2009

Pulmonary function measures are heritable traits that predict morbidity and mortality and define chronic obstructive pulmonary disease (COPD). We tested genome-wide association with forced expiratory volume in 1 s (FEV(1)) and the ratio of FEV(1) to forced vital capacity (FVC) in the SpiroMeta consortium (n = 20,288 individuals of European ancestry). We conducted a meta-analysis of top signals with data from direct genotyping (n < or = 32,184 additional individuals) and in silico summary association data from the CHARGE Consortium (n = 21,209) and the Health 2000 survey (n < or = 883). We confirmed the reported locus at 4q31 and identified associations with FEV(1) or FEV(1)/FVC and co…

OncologySpirometryMalemedicine.medical_specialtyVital capacityPopulationReceptor for Advanced Glycation End ProductsVital CapacityGenome-wide association studyBiologyPolymorphism Single NucleotideArticlePulmonary function testing03 medical and health sciencesFEV1/FVC ratioPulmonary Disease Chronic Obstructive0302 clinical medicineMeta-Analysis as TopicInternal medicineTensinsForced Expiratory VolumeGeneticsmedicineHumansRNA MessengerReceptors ImmunologiceducationLung030304 developmental biologyGlutathione Transferase0303 health scienceseducation.field_of_studyCOPDmedicine.diagnostic_testGenome HumanGene Expression ProfilingMicrofilament Proteinsrespiratory systemmedicine.disease3. Good healthRespiratory Function Tests030228 respiratory systemSpirometryImmunologyFemaleReceptors Serotonin 5-HT4Hedgehog interacting proteinThrombospondinsGenome-Wide Association Study
researchProduct

In response: Genomic profile of breast cancer.

2015

Response to: Plun-Favreau J, Svedman C, Valentine W, Rouzier R. Genomic profile of breast cancer. Expert Rev Pharmacoecon Outcomes Res 2015;15(3):393–94We would like to express our gratitude for th...

Oncologymedicine.medical_specialtyNational Health Programsmedia_common.quotation_subjectBreast NeoplasmsBreast cancerMammaPrintInternal medicineGratitudemedicineBiomarkers TumorHumansPharmacology (medical)Genetic TestingPrecision Medicinemedia_commonmedicine.diagnostic_testbusiness.industryHealth PolicyGene Expression ProfilingGeneral MedicineHealth Care Costsmedicine.diseaseGenomic ProfileFemaleOncotype DXbusinessExpert review of pharmacoeconomicsoutcomes research
researchProduct

Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Dia…

2019

Circulating tumor DNA (ctDNA) has emerged as a non-invasive &ldquo

Oncologymedicine.medical_specialtymolecular profilinglcsh:MedicineDNA sequencing03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerInternal medicinemedicineMammographyLiquid biopsycirculating tumor DNA (ctDNA)GeneLymph node030304 developmental biology0303 health sciencesmedicine.diagnostic_testliquid biopsybusiness.industrylcsh:RGeneral MedicineAmpliconmedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisImmunohistochemistrybusinessearly-stage cancer
researchProduct

Multi-party metering: An architecture for privacy-preserving profiling schemes

2013

Several privacy concerns about the massive deploy- ment of smart meters have been arisen recently. Namely, it has been shown that the fine-grained temporal traces generated by these meters can be correlated with different users behaviors. A new architecture, called multi-party metering, for enabling privacy-preserving analysis of high-frequency metering data without requiring additional complexity at the smart meter side is here proposed. The idea is to allow multiple entities to get a share of the high-frequency metering data rather than the real data, where this share does not reveal any information about the real data. By aggregating the shares provided by different users and publishing …

OptimizationInformation privacyEngineeringtatistical analysiSmart meterDistributed computingpattern clusteringC.2 COMPUTER-COMMUNICATION NETWORKSSmart gridelectricity supply industryComputer securitycomputer.software_genreCOMPUTER-COMMUNICATION NETWORKSElectricityClustering algorithmProfiling (information science)Metering modemart meterIndexeArchitectureCluster analysisgas industrydata privacybusiness.industrySettore ING-INF/03 - TelecomunicazioniComplexity theoryreal gas consumption dataVectorsA sharehigh-frequency metering datamultiparty meteringInformation sensitivityynthetic electricity consumption dataCryptographyprivacy-preserving profiling schemeprivacy-preserving analysibusinesscomputeruser profiling clustering mechanismMulti-Party Metering
researchProduct

Comparative training procedures to learn odor descriptors: effects on profiling performance

1999

Three groups of ten naive assessors were recruited to perform an odor profiling of 10 orange juices using 8 odor descriptors, These panels differed on the way they learned each descriptor. Group 1R learned to match one descriptor with one external standard; group 3R learned to associate one descriptor with 3 external standards; group 0R defined by itself the 8 descriptors from a set of orange juices. Results showed that the use of one standard per descriptor seemed to be only efficient when the standard was typical of the odor perception in the orange juices. Learning one odor concept with 3 standards led to redundant use of discriminant descriptors and failed on the agreement among assesso…

Orange juice0303 health sciencesOdor perception030309 nutrition & dieteticsbusiness.industryComputer science[SDV]Life Sciences [q-bio]Pattern recognition04 agricultural and veterinary sciences040401 food scienceSensory analysisSensory Systems[SDV] Life Sciences [q-bio]03 medical and health sciences0404 agricultural biotechnologyOdorProfiling (information science)Statistical analysisFruit juiceArtificial intelligencebusinessComputingMilieux_MISCELLANEOUSFood Science
researchProduct